The Bloomington, Indiana facility is a fill-finish site for Regeneron’s Eylea HD and odronextamab and handles the final stages of drug preparation and packaging.
The collaboration will embed AI-driven modeling into Repligen’s tangential flow filtration systems to speed process development, according to the companies.
Pharmaceutical manufacturers often accept avoidable limitations of ULT freezers, such as temperature fluctuations, large footprints, and reactive maintenance. They should be demanding ULT freezers that are engineered to break the status quo.
